← Browse by Condition
Medical Condition

advanced salivary gland carcinoma

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 1
NCT04704661 Phase 1
Recruiting

Testing the Combination of Two Anti-cancer Drugs, DS-8201a and AZD6738, for The Treatment of Advanced Solid Tumors Expressing the HER2 Protein or Gene, The DASH Trial

Enrollment
51 pts
Location
United States
Sponsor
National Cancer Institute (NCI...
View Trial →